Latest news in cancer
Targeting FGFR4 and CD276 with CAR T-cells demonstrates a strong antitumor impact against children rhabdomyosarcoma
Chimeric antigen receptor (CAR) T-cells that specifically target Fibroblast Growth Factor Receptor 4 (FGFR4), a surface tyrosine receptor that is extensively...
Disruption of CD5 on CAR T Cells Enhances the Effectiveness of Anti-Tumor Treatment
CAR T-Cell therapy in the treatment of cancer A preclinical study conducted by researchers at the University of Pennsylvania’s Perelman School of...
The future of gene therapy: What to expect in the next decade?
Gene therapy Gene therapy, which means changing genes to cure or avert diseases, has progressed significantly in the last number of years. The future of gene...
Unlocking the genetic code: The future of gene therapy for genetic disorders
Gene therapy has typified the revolution in medicine that gives hope to various genetic disorders. This advanced treatment stops, and sometimes even reverses,...
CRISPR and gene editing: Revolutionizing gene therapy
This makes the CRISPR-Cas9 technology one of the most potent tools known in gene therapy for very accurate, efficient, and versatile genome editing; it has...
Gene therapy in treating cancer: Success stories and challenges
Gene therapy is shifting concepts in cancer treatments from genes to boosting immune responses. The success stories are CAR-T cell therapies like Kymriah...
The history and evolution of gene therapy
Gene therapy has truly traveled a distance—from its conceptual roots dating back to the mid-20th century to its modern claim to fame with CRISPR technology....
Gene therapy in China
Gene therapy in China is rapidly advancing because of massive investment in research and development. Equipped with state-of-the-art technology, such as...
First Gene Therapy for Children with Metachromatic Leukodystrophy is Approved by the FDA
FDA approval The U.S. Food and Drug Administration has granted Lenmeldy (atidarsagene autotemcel) approval. The FDA has approved this gene therapy as the first...
FDA approves gene therapy to treat beta thalassemia
The FDA has approved a groundbreaking gene therapy to treat beta thalassemia, a genetic blood disorder that requires regular blood transfusions. This...
First gene therapy approved by the USFDA to treat sickle cell disease
USFDA approved gene therapy for sickle cell disease The U.S. Food and Drug Administration has granted approval for two significant medications, Casgevy and...
Gene Therapy for Thalassemia
Gene therapy for thalassemia is a groundbreaking treatment that targets the genetic roots of the disease. By introducing functional copies of the beta-globin...
Need help? Our team is ready to assist you.
We wish a speedy recovery of your dear and near one.